- Home
- AVTX vs ABR Comparison
AVTX vs ABR Comparison
Compare AVTX & ABR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | AVTX | ABR |
|---|---|---|
| Founded | 2011 | 2003 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 710.1M | 809.7M |
| IPO Year | 2015 | 2003 |
Fundamental Metrics
Financial Performance| Metric | AVTX | ABR |
|---|---|---|
| Price | $7.81 | $1.28 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 14 | 5 |
| Target Price | ★ $34.80 | $2.25 |
| AVG Volume (30 Days) | 2.9M | ★ 9.1M |
| Earning Date | 11-05-2026 | 10-30-2026 |
| Dividend Yield | N/A | ★ 72.31% |
| EPS Growth | ★ 72.07 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $27,813,137.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 2312.27 | N/A |
| 52 Week Low | $6.53 | $1.28 |
| 52 Week High | $24.27 | $9.30 |
Technical Indicators
Market Signals| Indicator | AVTX | ABR |
|---|---|---|
| Relative Strength Index (RSI) | 38.51 | 14.22 |
| Support Level | $6.53 | N/A |
| Resistance Level | $20.54 | $5.38 |
| Average True Range (ATR) | 0.62 | 0.15 |
| MACD | 0.36 | -0.05 |
| Stochastic Oscillator | 62.35 | 0.28 |
Price Performance
Historical ComparisonAbout AVTX Avalo Therapeutics Inc.
Avalo Therapeutics Inc is a clinical stage biotechnology company fully dedicated to developing IL-1B-based treatments for immune-mediated inflammatory diseases. The company's asset is Abdakibart (AVTX-009) an anti-IL-1B monoclonal antibody ("mAb"), targeting inflammatory diseases. Avalos pipeline also includes quisovalimab (anti-LIGHT mAb) and AVTX-008 (BTLA agonist fusion protein), AVTX-006 and AVTX-913.
About ABR Arbor Realty Trust
Arbor Realty Trust Inc is a specialized real estate finance company. It invests in a diversified portfolio of structured finance assets in the multifamily, SFR, and commercial real estate markets, consisting of bridge and mezzanine loans, including junior participating interests in first mortgages, preferred, and direct equity. In addition, it may also directly acquire real property and invest in real estate-related notes and certain mortgage-related securities. The company has two business segments, Structured Business and Agency Business. It generates a majority of its revenue from the Structured Business Segment.